Skip to main content
Clinical Trials/NCT00637546
NCT00637546
Completed
Phase 2

Efficacy of a Specific Physiotherapy Group Treatment on Gait and Balance in Patients With Diabetic Neuropathy

University Hospital, Geneva1 site in 1 country71 target enrollmentSeptember 2007
ConditionsDiabetes Type 2

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabetes Type 2
Sponsor
University Hospital, Geneva
Enrollment
71
Locations
1
Primary Endpoint
Gait parameter: comfortable speed
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

Type 2 diabetes is one of the fastest growing public health problems in both developed and developing countries. It is estimated that the number of people with diabetes in the world will double in coming years, from 171 million in 2000 to 366 million in 2030.The role of physiotherapy in diabetic care is to reduce immobilisation effects, to maintain functional capacity and to minimise diabetes-related complications. The physiotherapist also has a role in providing advice about exercise and daily living activities. The fundamental principle of rehabilitation is to improve quality of life while diminishing the health care burden. By reducing the heightened risk of falling, the fall related injuries and the fear of falling one could improve quality of life in diabetic patients and reduce health care costs.

The goal of this study is to investigate the effectiveness of gait and balance training in pre frail subgroup diabetes patients. Our program is based on recommendations of Robertson et al.(2002) and Page et al.(2002) The investigators randomly assign patients in a control group (no treatment) or in a treatment group. The treatment program consists of two group sessions per week over 12 weeks. Patients were encouraged to perform specific home exercises. After this 12-week program, patients were asked to continue their exercises. The effect of the treatment will be evaluated after the treatment program and after a 6-month follow up.

Registry
clinicaltrials.gov
Start Date
September 2007
End Date
March 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Past or present patient from the University Hospital in Geneva
  • Diagnosed with diabetes by the medical doctor (glycaemia \> 7 mmol on two different tests on an empty stomach)
  • Presence of a peripheral neuropathy (vibration perception ≤ 4)

Exclusion Criteria

  • Patients with a foot ulcer at the moment of intake
  • Patients with orthopaedic or chirurgical problems influencing gait parameters
  • Patients with a non diabetic neuropathy (Charcot, alcohol, Thyroid dysfunction)
  • Patients with neurological problems influencing gait parameters
  • Patients with incapacity to walk without a walking aid

Outcomes

Primary Outcomes

Gait parameter: comfortable speed

Time Frame: Before treatment / After treatment / 6 month follow up

Secondary Outcomes

  • Fear of falling (Falls efficacy scale)(Before Treatment / After Treatment / 6 month follow up)
  • Other spatio temporal gait parameters and sagittal movement of lower limb(Before Treatment/ After Treatment/ 6 month follow up)
  • Balance measures (Tinetti and Biodex balance Index, acceleration on sacrum)(Before Treatment / After Treatment / 6 month follow up)

Study Sites (1)

Loading locations...

Similar Trials